Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Schrimpf

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica|June 6, 2022
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastomaSebastian Adeberg, Maximilian Knoll, Christian Koelsche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 TrialTobias Kessler, Daniel Schrimpf, Laura Doerner, et al.
Acta Neuropathologica|September 7, 2022
Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinasesPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Nature Communications|October 28, 2025
DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasmsBenjamin Goeppert, Alphonse Charbel, Reka Toth, et al.
Neuro-Oncology|March 5, 2025
High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy resistant subgroups and MYC immunohistochemistry as a powerful outcome predictorAlberto Delaidelli, Fares Burwag, Susana Ben-Neriah, et al.
Neuro-Oncology|November 23, 2017
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot studyElke Pfaff, Tobias Kessler, Gnana Prakash Balasubramanian, et al.
Acta Neuropathologica|March 11, 2015
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markersAndrey Korshunov, Marina Ryzhova, Volker Hovestadt, et al.
Acta Neuropathologica|October 21, 2015
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entityAndrey Korshunov, David Capper, David Reuss, et al.
Acta Neuropathologica Communications|November 6, 2025
Employing nanopore sequencing on FFPE-derived DNA for CNS tumor diagnosticsPaul Kerbs, Michelle Brehm, Daniel Haag, et al.
Acta Neuropathologica|September 8, 2021
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomasElmar Kirches, Felix Sahm, Andrey Korshunov, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica|June 6, 2022
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastomaSebastian Adeberg, Maximilian Knoll, Christian Koelsche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 TrialTobias Kessler, Daniel Schrimpf, Laura Doerner, et al.
Acta Neuropathologica|September 7, 2022
Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinasesPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Nature Communications|October 28, 2025
DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasmsBenjamin Goeppert, Alphonse Charbel, Reka Toth, et al.
Neuro-Oncology|March 5, 2025
High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy resistant subgroups and MYC immunohistochemistry as a powerful outcome predictorAlberto Delaidelli, Fares Burwag, Susana Ben-Neriah, et al.
Neuro-Oncology|November 23, 2017
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot studyElke Pfaff, Tobias Kessler, Gnana Prakash Balasubramanian, et al.
Acta Neuropathologica|March 11, 2015
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markersAndrey Korshunov, Marina Ryzhova, Volker Hovestadt, et al.
Acta Neuropathologica|October 21, 2015
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entityAndrey Korshunov, David Capper, David Reuss, et al.
Acta Neuropathologica Communications|November 6, 2025
Employing nanopore sequencing on FFPE-derived DNA for CNS tumor diagnosticsPaul Kerbs, Michelle Brehm, Daniel Haag, et al.
Acta Neuropathologica|September 8, 2021
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomasElmar Kirches, Felix Sahm, Andrey Korshunov, et al.
Pageof 13